MELAMAG Trial: SentiMAG Melanoma

• Research type

  Research Study

• Full title

  MELAMAG Trial: SentiMAG Melanoma Sentinel Node Biopsy using Magnetic Nanoparticles: A prospective multicentre feasibility non-randomised clinical trial to compare sentinel node biopsy using magnetic nanoparticles vs. standard technique

• IRAS ID

  115520

• Contact name

  Michael Douek

• Contact email

  michael.douek@kcl.ac.uk

• REC name

  East of England - Cambridge Central Research Ethics Committee

• REC reference

  12/EE/0522

• Date of REC Opinion

  7 Feb 2013

• REC opinion

  Further Information Favourable Opinion